GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK)

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
279,154,423
Share change
-755,529
Total reported value
$11,177,183,564
Put/Call ratio
80%
Price per share
$40.02
Number of holders
795
Value change
-$33,533,667
Number of buys
336
Number of sells
374

Institutional Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q2 2019

As of 30 Jun 2019, GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) was held by 795 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 279,154,423 shares. The largest 10 holders included Dodge & Cox, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, ROYAL BANK OF CANADA, STATE STREET CORP, Black Creek Investment Management Inc., BANK OF AMERICA CORP /DE/, and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC. This page lists 795 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.